761 related articles for article (PubMed ID: 34047448)
1. Soyasaponin A
Xiong F; Zheng Z; Xiao L; Su C; Chen J; Gu X; Tang J; Zhao Y; Luo H; Zha L
Mol Nutr Food Res; 2021 Jul; 65(14):e2100067. PubMed ID: 34047448
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbiota Plays Essential Roles in Soyasaponin's Preventive Bioactivities against Steatohepatitis in the Methionine and Choline Deficient (MCD) Diet-Induced Non-Alcoholic Steatohepatitis (NASH) Mice.
Su C; Wang J; Luo H; Chen J; Lin F; Mo J; Xiong F; Zha L
Mol Nutr Food Res; 2024 Feb; 68(4):e2300561. PubMed ID: 38234006
[TBL] [Abstract][Full Text] [Related]
3. Intermittent Fasting Alleviates Non-Alcoholic Steatohepatitis by Regulating Bile Acid Metabolism and Promoting Fecal Bile Acid Excretion in High-Fat and High-Cholesterol Diet Fed Mice.
Lin X; Zhu X; Xin Y; Zhang P; Xiao Y; He T; Guo H
Mol Nutr Food Res; 2023 Jul; 67(14):e2200595. PubMed ID: 37148502
[TBL] [Abstract][Full Text] [Related]
4. Dihydromyricetin ameliorated nonalcoholic steatohepatitis in mice by regulating the composition of serous lipids, bile acids and ileal microflora.
Miao X; Luo P; Liu J; Wang J; Chen Y
Lipids Health Dis; 2023 Aug; 22(1):112. PubMed ID: 37533083
[TBL] [Abstract][Full Text] [Related]
5. Salvia-Nelumbinis naturalis extract protects mice against MCD diet-induced steatohepatitis via activation of colonic FXR-FGF15 pathway.
Li C; Zhou W; Li M; Shu X; Zhang L; Ji G
Biomed Pharmacother; 2021 Jul; 139():111587. PubMed ID: 33865013
[TBL] [Abstract][Full Text] [Related]
6. Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice.
Li Q; Li M; Li F; Zhou W; Dang Y; Zhang L; Ji G
J Ethnopharmacol; 2020 Aug; 258():112896. PubMed ID: 32325178
[TBL] [Abstract][Full Text] [Related]
7. Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis.
Ye JZ; Li YT; Wu WR; Shi D; Fang DQ; Yang LY; Bian XY; Wu JJ; Wang Q; Jiang XW; Peng CG; Ye WC; Xia PC; Li LJ
World J Gastroenterol; 2018 Jun; 24(23):2468-2481. PubMed ID: 29930468
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH.
Hernandez GV; Smith VA; Melnyk M; Burd MA; Sprayberry KA; Edwards MS; Peterson DG; Bennet DC; Fanter RK; Columbus DA; Steibel JP; Glanz H; Immoos C; Rice MS; Santiago-Rodriguez TM; Blank J; VanderKelen JJ; Kitts CL; Piccolo BD; La Frano MR; Burrin DG; Maj M; Manjarin R
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G582-G609. PubMed ID: 32003601
[TBL] [Abstract][Full Text] [Related]
9. Honokiol affects the composition of gut microbiota and the metabolism of lipid and bile acid in methionine-choline deficiency diet-induced NASH mice.
Zhai T; Wang J; Chen Y
Sci Rep; 2023 Sep; 13(1):15203. PubMed ID: 37709801
[TBL] [Abstract][Full Text] [Related]
10. Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota-bile acid-farnesoid X receptor axis.
Li H; Xi Y; Xin X; Tian H; Hu Y
Biomed Pharmacother; 2020 Apr; 124():109915. PubMed ID: 31986416
[TBL] [Abstract][Full Text] [Related]
11. Lactobacillus casei strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model.
Okubo H; Sakoda H; Kushiyama A; Fujishiro M; Nakatsu Y; Fukushima T; Matsunaga Y; Kamata H; Asahara T; Yoshida Y; Chonan O; Iwashita M; Nishimura F; Asano T
Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(12):G911-8. PubMed ID: 24113768
[TBL] [Abstract][Full Text] [Related]
12. Mosapride citrate improves nonalcoholic steatohepatitis with increased fecal lactic acid bacteria and plasma glucagon-like peptide-1 level in a rodent model.
Okubo H; Nakatsu Y; Sakoda H; Kushiyama A; Fujishiro M; Fukushima T; Matsunaga Y; Ohno H; Yoneda M; Kamata H; Shinjo T; Iwashita M; Nishimura F; Asano T
Am J Physiol Gastrointest Liver Physiol; 2015 Jan; 308(2):G151-8. PubMed ID: 25428903
[TBL] [Abstract][Full Text] [Related]
13. Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis.
Wu W; Liu X; Peng X; Xue R; Ji L; Shen X; Chen S; Gu J; Zhang S
Biochem Biophys Res Commun; 2014 May; 448(1):50-5. PubMed ID: 24747563
[TBL] [Abstract][Full Text] [Related]
14. Intestinal Microbiota Protects against MCD Diet-Induced Steatohepatitis.
Schneider KM; Mohs A; Kilic K; Candels LS; Elfers C; Bennek E; Schneider LB; Heymann F; Gassler N; Penders J; Trautwein C
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646522
[TBL] [Abstract][Full Text] [Related]
15. Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut-Liver Axis.
Yang C; Wan M; Xu D; Pan D; Xia H; Yang L; Sun G
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639207
[TBL] [Abstract][Full Text] [Related]
16. Qingrequzhuo capsule alleviated methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice through regulating gut microbiota, enhancing gut tight junction and inhibiting the activation of TLR4/NF-κB signaling pathway.
Lv S; Zhang Z; Su X; Li W; Wang X; Pan B; Li H; Zhang H; Wang Y
Front Endocrinol (Lausanne); 2022; 13():1106875. PubMed ID: 36743916
[TBL] [Abstract][Full Text] [Related]
17. Isotschimgine alleviates nonalcoholic steatohepatitis and fibrosis via FXR agonism in mice.
Li J; Liu C; Zhou Z; Dou B; Huang J; Huang L; Zheng P; Fan S; Huang C
Phytother Res; 2021 Jun; 35(6):3351-3364. PubMed ID: 33784797
[TBL] [Abstract][Full Text] [Related]
18. Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites.
Zhu M; Wang X; Wang K; Zhao Z; Dang Y; Ji G; Li F; Zhou W
Front Cell Infect Microbiol; 2023; 13():1066053. PubMed ID: 36779187
[TBL] [Abstract][Full Text] [Related]
19. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.
Mouries J; Brescia P; Silvestri A; Spadoni I; Sorribas M; Wiest R; Mileti E; Galbiati M; Invernizzi P; Adorini L; Penna G; Rescigno M
J Hepatol; 2019 Dec; 71(6):1216-1228. PubMed ID: 31419514
[TBL] [Abstract][Full Text] [Related]
20. Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis.
Tanaka N; Matsubara T; Krausz KW; Patterson AD; Gonzalez FJ
Hepatology; 2012 Jul; 56(1):118-29. PubMed ID: 22290395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
